GP
CELG

Girard Partners’s Celgene Corp CELG Stock Holding History

Girard Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,490
Closed -$843K – 233
2019
Q3 		$843K Sell
8,490
-500
-6% -$47.5K 0.16% 119
2019
Q2 		$831K Sell
8,990
-5
-0.1% -$475 0.15% 123
2019
Q1 		$848K Sell
8,995
-1,636
-15% -$143K 0.16% 123
2018
Q4 		$681K Sell
10,631
-5,124
-33% -$378K 0.14% 128
2018
Q3 		$1.41M Sell
15,755
-1,672
-10% -$148K 0.25% 97
2018
Q2 		$1.38M Buy
17,427
+2,139
+14% +$178K 0.26% 99
2018
Q1 		$1.36M Buy
15,288
+2,247
+17% +$216K 0.32% 81
2017
Q4 		$1.36M Sell
13,041
-1,697
-12% -$191K 0.26% 98
2017
Q3 		$2.15M Buy
14,738
+319
+2% +$43.5K 0.44% 68
2017
Q2 		$1.87M Buy
14,419
+1,510
+12% +$185K 0.41% 71
2017
Q1 		$1.61M Buy
12,909
+2,061
+19% +$247K 0.39% 79
2016
Q4 		$1.26M Sell
10,848
-152
-1% -$16.9K 0.36% 79
2016
Q3 		$1.15M Buy
11,000
+502
+5% +$54.3K 0.38% 74
2016
Q2 		$1.03M Buy
10,498
+896
+9% +$92.7K 0.39% 77
2016
Q1 		$961K Buy
9,602
+1,354
+16% +$139K 0.42% 71
2015
Q4 		$988K Buy
8,248
+5
+0.1% +$578 0.48% 68
2015
Q3 		$892K Buy
8,243
+40
+0.5% +$4.96K 0.51% 69
2015
Q2 		$949K Buy
8,203
+915
+13% +$105K 0.53% 64
2015
Q1 		$840K Buy
7,288
+910
+14% +$109K 0.5% 69
2014
Q4 		$713K Buy
6,378
+2,070
+48% +$218K 0.45% 69
2014
Q3 		$408K Buy
4,308
+450
+12% +$40.6K 0.27% 92
2014
Q2 		$331K Buy
+3,858
New +$293K 0.23% 103

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Girard Partners's CELG Position: Q4 2019 in Review

Girard Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,490 shares — an estimated $843K sold.

Girard Partners first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $2.15M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Girard Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Girard Partners sold 8,490 Celgene Corp shares in Q4 2019, an estimated $843K.
  • Girard Partners first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
  • Girard Partners's Celgene Corp position peaked at $2.15M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Girard Partners's 13F filing for Q4 2019, filed 3 Feb 2020.